利奈唑胺对葡萄球菌的体外活性。 - Suppr

Suppr

超能文献

In vitro activity of linezolid against staphylococci.

作者信息

Cuny C, Witte W

机构信息

Robert Koch Institute, Wernigerode Branch, Burgstr. 37, 38855 Wernigerode, Germany.

出版信息

Clin Microbiol Infect. 2000 Jun;6(6):331-3. doi: 10.1046/j.1469-0691.2000.006006331.x.

DOI:10.1046/j.1469-0691.2000.006006331.x

PMID:11168144

Abstract

摘要

相似文献

In vitro activity of linezolid against staphylococci.

Clin Microbiol Infect. 2000 Jun;6(6):331-3. doi: 10.1046/j.1469-0691.2000.006006331.x.

Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci.

J Antimicrob Chemother. 2001 Dec;48(6):911-3. doi: 10.1093/jac/48.6.911.

Introduction of erm(C) into a linezolid- and methicillin-resistant Staphylococcus aureus does not restore linezolid susceptibility.

J Antimicrob Chemother. 2003 Apr;51(4):1039-41. doi: 10.1093/jac/dkg194.

In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and -susceptible staphylococci and enterococci.

Antimicrob Agents Chemother. 2007 Mar;51(3):1112-4. doi: 10.1128/AAC.01347-06. Epub 2007 Jan 8.

Susceptibility testing with linezolid by different methods, in relation to published 'general breakpoints'.

J Antimicrob Chemother. 2001 Sep;48(3):452-4. doi: 10.1093/jac/48.3.452.

Activity of linezolid against levofloxacin-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in Hong Kong.

J Antimicrob Chemother. 2001 Oct;48(4):590-2. doi: 10.1093/jac/48.4.590.

In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey.

Braz J Microbiol. 2014 Oct 9;45(3):829-33. doi: 10.1590/s1517-83822014000300010. eCollection 2014.

In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.

Microb Drug Resist. 2003 Winter;9(4):389-93. doi: 10.1089/107662903322762833.

Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.

J Infect Dis. 2002 Dec 1;186(11):1603-7. doi: 10.1086/345368. Epub 2002 Nov 4.

Activity of linezolid and daptomycin against methicillin-resistant coagulase-negative staphylococci with increased MIC for vancomycin isolated from blood cultures in pediatric patients.

J Chemother. 2014 Oct;26(5):273-5. doi: 10.1179/1973947813Y.0000000134. Epub 2013 Dec 6.

引用本文的文献

The Relationship between Ciprofloxacin Resistance and Genotypic Changes in Ocular Isolates.

Pathogens. 2022 Nov 15;11(11):1354. doi: 10.3390/pathogens11111354.

Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing.

Antimicrob Agents Chemother. 2007 Apr;51(4):1508-11. doi: 10.1128/AAC.01517-06. Epub 2007 Jan 29.

Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin.

Antimicrob Agents Chemother. 2005 Oct;49(10):4210-9. doi: 10.1128/AAC.49.10.4210-4219.2005.

Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.

Antimicrob Agents Chemother. 2005 Aug;49(8):3325-33. doi: 10.1128/AAC.49.8.3325-3333.2005.

Role of mutS and mutL genes in hypermutability and recombination in Staphylococcus aureus.

J Bacteriol. 2005 May;187(10):3455-64. doi: 10.1128/JB.187.10.3455-3464.2005.

Antistaphylococcal activity of dalbavancin, an experimental glycopeptide.

Antimicrob Agents Chemother. 2005 Feb;49(2):770-2. doi: 10.1128/AAC.49.2.770-772.2005.

Antistaphylococcal activity of CB-181963 (CAB-175), an experimental parenteral cephalosporin.

Antimicrob Agents Chemother. 2004 Oct;48(10):4037-9. doi: 10.1128/AAC.48.10.4037-4039.2004.

Antistaphylococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.

Antimicrob Agents Chemother. 2004 Oct;48(10):4033-6. doi: 10.1128/AAC.48.10.4033-4036.2004.

Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents.

Antimicrob Agents Chemother. 2003 Mar;47(3):1148-50. doi: 10.1128/AAC.47.3.1148-1150.2003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

In vitro activity of linezolid against staphylococci.

Clin Microbiol Infect. 2000 Jun;6(6):331-3. doi: 10.1046/j.1469-0691.2000.006006331.x.

Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci.

J Antimicrob Chemother. 2001 Dec;48(6):911-3. doi: 10.1093/jac/48.6.911.

Introduction of erm(C) into a linezolid- and methicillin-resistant Staphylococcus aureus does not restore linezolid susceptibility.

J Antimicrob Chemother. 2003 Apr;51(4):1039-41. doi: 10.1093/jac/dkg194.

In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and -susceptible staphylococci and enterococci.

Antimicrob Agents Chemother. 2007 Mar;51(3):1112-4. doi: 10.1128/AAC.01347-06. Epub 2007 Jan 8.

Susceptibility testing with linezolid by different methods, in relation to published 'general breakpoints'.

J Antimicrob Chemother. 2001 Sep;48(3):452-4. doi: 10.1093/jac/48.3.452.

Activity of linezolid against levofloxacin-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in Hong Kong.

J Antimicrob Chemother. 2001 Oct;48(4):590-2. doi: 10.1093/jac/48.4.590.

In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey.

Braz J Microbiol. 2014 Oct 9;45(3):829-33. doi: 10.1590/s1517-83822014000300010. eCollection 2014.

Microb Drug Resist. 2003 Winter;9(4):389-93. doi: 10.1089/107662903322762833.

Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.

J Infect Dis. 2002 Dec 1;186(11):1603-7. doi: 10.1086/345368. Epub 2002 Nov 4.

Activity of linezolid and daptomycin against methicillin-resistant coagulase-negative staphylococci with increased MIC for vancomycin isolated from blood cultures in pediatric patients.

J Chemother. 2014 Oct;26(5):273-5. doi: 10.1179/1973947813Y.0000000134. Epub 2013 Dec 6.

引用本文的文献

The Relationship between Ciprofloxacin Resistance and Genotypic Changes in Ocular Isolates.

Pathogens. 2022 Nov 15;11(11):1354. doi: 10.3390/pathogens11111354.

Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing.

Antimicrob Agents Chemother. 2007 Apr;51(4):1508-11. doi: 10.1128/AAC.01517-06. Epub 2007 Jan 29.

Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin.

Antimicrob Agents Chemother. 2005 Oct;49(10):4210-9. doi: 10.1128/AAC.49.10.4210-4219.2005.

Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.

Antimicrob Agents Chemother. 2005 Aug;49(8):3325-33. doi: 10.1128/AAC.49.8.3325-3333.2005.

Role of mutS and mutL genes in hypermutability and recombination in Staphylococcus aureus.

J Bacteriol. 2005 May;187(10):3455-64. doi: 10.1128/JB.187.10.3455-3464.2005.

Antistaphylococcal activity of dalbavancin, an experimental glycopeptide.

Antimicrob Agents Chemother. 2005 Feb;49(2):770-2. doi: 10.1128/AAC.49.2.770-772.2005.

Antistaphylococcal activity of CB-181963 (CAB-175), an experimental parenteral cephalosporin.

Antimicrob Agents Chemother. 2004 Oct;48(10):4037-9. doi: 10.1128/AAC.48.10.4037-4039.2004.

Antistaphylococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.

Antimicrob Agents Chemother. 2004 Oct;48(10):4033-6. doi: 10.1128/AAC.48.10.4033-4036.2004.

Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents.

Antimicrob Agents Chemother. 2003 Mar;47(3):1148-50. doi: 10.1128/AAC.47.3.1148-1150.2003.

In vitro activity of linezolid against staphylococci.

作者信息

Cuny C, Witte W

机构信息

Robert Koch Institute, Wernigerode Branch, Burgstr. 37, 38855 Wernigerode, Germany.

出版信息

Clin Microbiol Infect. 2000 Jun;6(6):331-3. doi: 10.1046/j.1469-0691.2000.006006331.x.

DOI:10.1046/j.1469-0691.2000.006006331.x

PMID:11168144

Abstract

摘要